Purpose: To evaluate the spatial relationship between mid-phase hyperfluorescent plaques (MPHP) and choroidal vascularity in central serous chorioretinopathy (CSCR) using choroidal vascularity index (CVI) heat maps and enrichment ratio (ER) analysis. Design: Retrospective multicenter study. Subjects: Forty eyes from 40 patients with CSCR presenting MPHP on indocyanine green angiography (ICGA) at both baseline and follow-up were included. Methods: Choroidal vascularity index was calculated from spectral-domain OCT scans using an automated algorithm generating en face CVI heat maps. Mid-phase hyperfluorescent plaques areas were manually segmented after overlaying with ICGA images. Spatial association between MPHP and high-CVI regions was assessed using ER analysis at absolute CVI thresholds of 0.75 and 0.90. Eyes were further stratified according to MPHP area dynamics (increased vs. decreased) at follow-up. Main Outcome Measures: Mean CVI inside versus outside the MPHP area; ER values at CVI thresholds of 0.75 and 0.90; intralesional CVI distribution; ER values by MPHP area dynamics subgroup. Results: Mean CVI was significantly higher within the MPHP area (0.72 ± 0.09) compared with the surrounding choroid (0.70 ± 0.09; paired Wilcoxon P < 0.01; mean difference, 0.022; 95% confidence interval, 0.010–0.033; Cohen d = 0.57). Enrichment ratio analysis demonstrated preferential localization of MPHP within high-CVI regions at the CVI threshold of 0.90 (ER > 0.90 = 1.67). Qualitative assessment revealed nonuniform intralesional CVI distribution in 70% of eyes. In subgroup analysis, eyes with increasing MPHP area showed a directional trend toward greater enrichment within regions of highest CVI values (ER > 0.90: median 1.43 vs. 0.84; t test P = 0.04, Mann-Whitney P = 0.260), an exploratory finding. Conclusions: Mid-phase hyperfluorescent plaques in CSCR are spatially associated with regions of increased choroidal vascularity, supporting a spatially driven model of disease. These hypothesis-generating findings highlight the potential value of CVI-based spatial mapping for improving disease characterization and, pending prospective validation, therapeutic targeting. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Spatial Choroidal Analysis under Mid-Phase Hyperfluorescent Plaques Demonstrates Unique Signatures in Central Serous Chorioretinopathy: Macula Society International Central Serous Chorioretinopathy Research Network Report Number 20 / Gregori, G., Sahoo, N.K., Hasan, N., Vichare, A.A., Lall, S.R., Chandra Vupparaboina, S., Gadari, A., Gagliardi, O.M., Lupidi, M., Mariotti, C., Saju, S., Cao, J., Wykoff, C.C., Vupparaboina, K.K., Chandra Bollepalli, S., Wu, L., Chhablani, J.. - In: OPHTHALMOLOGY SCIENCE. - ISSN 2666-9145. - 6:11(2026). [10.1016/j.xops.2026.101404]

Spatial Choroidal Analysis under Mid-Phase Hyperfluorescent Plaques Demonstrates Unique Signatures in Central Serous Chorioretinopathy: Macula Society International Central Serous Chorioretinopathy Research Network Report Number 20

Gregori G.;Lupidi M.;Mariotti C.;
2026-01-01

Abstract

Purpose: To evaluate the spatial relationship between mid-phase hyperfluorescent plaques (MPHP) and choroidal vascularity in central serous chorioretinopathy (CSCR) using choroidal vascularity index (CVI) heat maps and enrichment ratio (ER) analysis. Design: Retrospective multicenter study. Subjects: Forty eyes from 40 patients with CSCR presenting MPHP on indocyanine green angiography (ICGA) at both baseline and follow-up were included. Methods: Choroidal vascularity index was calculated from spectral-domain OCT scans using an automated algorithm generating en face CVI heat maps. Mid-phase hyperfluorescent plaques areas were manually segmented after overlaying with ICGA images. Spatial association between MPHP and high-CVI regions was assessed using ER analysis at absolute CVI thresholds of 0.75 and 0.90. Eyes were further stratified according to MPHP area dynamics (increased vs. decreased) at follow-up. Main Outcome Measures: Mean CVI inside versus outside the MPHP area; ER values at CVI thresholds of 0.75 and 0.90; intralesional CVI distribution; ER values by MPHP area dynamics subgroup. Results: Mean CVI was significantly higher within the MPHP area (0.72 ± 0.09) compared with the surrounding choroid (0.70 ± 0.09; paired Wilcoxon P < 0.01; mean difference, 0.022; 95% confidence interval, 0.010–0.033; Cohen d = 0.57). Enrichment ratio analysis demonstrated preferential localization of MPHP within high-CVI regions at the CVI threshold of 0.90 (ER > 0.90 = 1.67). Qualitative assessment revealed nonuniform intralesional CVI distribution in 70% of eyes. In subgroup analysis, eyes with increasing MPHP area showed a directional trend toward greater enrichment within regions of highest CVI values (ER > 0.90: median 1.43 vs. 0.84; t test P = 0.04, Mann-Whitney P = 0.260), an exploratory finding. Conclusions: Mid-phase hyperfluorescent plaques in CSCR are spatially associated with regions of increased choroidal vascularity, supporting a spatially driven model of disease. These hypothesis-generating findings highlight the potential value of CVI-based spatial mapping for improving disease characterization and, pending prospective validation, therapeutic targeting. Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
2026
CSC; ER; MPHP
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/367123
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact